Mānuka honey is unlike any other, with over 2,000 natural bioactive compounds, surpassing the mere 100 found in average pasture honey. One of its most extraordinary elements is methylglyoxal, renowned for its healing properties, capable of healing wounds, burns, and combating antibiotic-resistant bacteria.
Each batch of Comvita Mānuka honey undergoes a rigorous process of more than 34 quality tests, ensuring the utmost quality and potency. Our commitment to authenticity, purity, and potency is unwavering, as we implement a rigorous "hive-to-home" testing program. Ensuring that every Comvita product meets the highest standards.
Embodying our dedication to excellence, Comvita MediHoney, known for its wound healing capabilities, was the first honey in the world to receive FDA approval as a medical device in the United States, trusted and used in thousands of hospitals worldwide.
With unyielding passion and relentless dedication, Comvita's world-leading expertise in Mānuka honey continues to pioneer the path of health and wellness for all.
Over 50 years of healing, led by science
Founded in 1974, Comvita stands as the global leader and a pioneering investor in Mānuka honey science.
Our research and development program is committed to exploring the effects of our patented compound, Comvita Lepteridine®, on gut inflammation, microbiota, and immunity in individuals with functional dyspepsia. Moreover, we're investigating the potential of Mānuka honey in alleviating atopic dermatitis and combating antimicrobial-resistant lung infections in individuals with cystic fibrosis.
As part of a government-supported intervention study, we're exploring the holistic impact of a diet that includes Mānuka honey on cardiometabolic health and type 2 diabetes.
